β-Lactams against Tuberculosis--New Trick for an Old Dog?
about
Repurposing clinically approved cephalosporins for tuberculosis therapyNon-classical transpeptidases yield insight into new antibacterialsThe safety and tolerability of the second-line injectable antituberculosis drugs in children.Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis.Time Trends in Sputum Mycobacterial Load and Two-Day Bactericidal Activity of Isoniazid-Containing Antituberculosis Therapies.Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.Targeting Phenotypically Tolerant Mycobacterium tuberculosis.Distinct Spatiotemporal Dynamics of Peptidoglycan Synthesis between Mycobacterium smegmatis and Mycobacterium tuberculosis.Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.Isolation unit for multidrug-resistant tuberculosis patients in a low endemic country, a step towards the World Health Organization End TB Strategy.2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.Reversible inactivation of a peptidoglycan transpeptidase by a β-lactam antibiotic mediated by β-lactam-ring recyclization in the enzyme active site.Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives.Respiratory infection: insights from Assembly 10 of the European Respiratory Society 2017 Annual Congress.Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.Inhibition of β-lactamases of mycobacteria by avibactam and clavulanate.Targeting the Proteostasis Network for Mycobacterial Drug Discovery.Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial.New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future
P2860
Q28828720-8EBBAB1F-0176-490E-B205-9F3C8E68289DQ33814192-B59722CD-8B99-47B5-AB36-D07B684124FBQ38933875-D13190A2-C12A-405E-9F75-AF51EEC924A2Q38991205-42B1F165-5DAC-4AD8-A4D1-CE7FF1379CB2Q38991212-5E64901E-47B2-4C40-B337-33D3C087DDF9Q39030679-9489EE7B-EB53-48F9-8548-EDE50CB47F82Q39149038-AC504275-D284-40AE-929D-58C364B04018Q40050409-37ED1DE0-5D10-47E2-A7C8-5AAB24C410C1Q40076101-A7E64076-7F60-4F6F-B9D9-A390B3A99AF7Q40187337-C3EBA0F0-0B0E-40F5-ACAE-978D473F9341Q40331838-8AC6FC7D-C78D-48A7-8BCE-1A3B1B82A280Q41293939-27090377-C845-4668-967A-4BBCF648C33CQ41489820-4BA69FF2-BE9C-4EAE-8567-CD80909AD0FAQ42369327-77B6D705-7BA4-47C8-81BD-94ECFCE5F9BFQ47105048-BD0514A3-87E0-4AB6-91E2-85C2E88D65E9Q47429675-402BE1C8-A8B6-4E5B-BA33-2DAA3797B91DQ51225225-2141E002-EE73-491B-A7DB-C2F2149024E3Q52692190-80D8A513-BC6C-4554-B164-F648812115D9Q53408541-235D7D44-4050-405E-919C-DAAB0F3B613DQ55650643-05BB1B18-80B9-46A1-88BB-656AEF80B4C3Q57158690-269C5C66-B234-48AF-89C7-0ADFE4BE7786
P2860
β-Lactams against Tuberculosis--New Trick for an Old Dog?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
β-Lactams against Tuberculosis--New Trick for an Old Dog?
@en
β-Lactams against Tuberculosis--New Trick for an Old Dog?
@nl
type
label
β-Lactams against Tuberculosis--New Trick for an Old Dog?
@en
β-Lactams against Tuberculosis--New Trick for an Old Dog?
@nl
prefLabel
β-Lactams against Tuberculosis--New Trick for an Old Dog?
@en
β-Lactams against Tuberculosis--New Trick for an Old Dog?
@nl
P2093
P356
P1476
β-Lactams against Tuberculosis--New Trick for an Old Dog?
@en
P2093
Alberto L García-Basteiro
Andreas H Diacon
David Barros-Aguirre
Esperança Sevene
Florian von Groote-Bidlingmaier
Lize van der Merwe
Marinus Barnard
P304
P356
10.1056/NEJMC1513236
P407
P577
2016-07-13T00:00:00Z